ArticleHarm reduction journal2025
Managing risks and harms associated with the use of anabolic steroids: a qualitative study.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPeople using anabolic steroids adopt different strategies to manage risks and harms associated with the use of these substances. We investigated how users learn, develop and incorporate risk-management strategies, as well as the events triggering changes in their health-related behaviour.
methodsTwenty semi-structured interviews were conducted with anabolic steroid users living in the UK to discuss their risk-management strategies (19 males, 1 female; median age = 35.5 years; median time of anabolic steroid use = 9 years). Online interviews were transcribed verbatim and qualitative data was analysed via iterative categorisation.
resultsThe use of risk-management strategies was characterised as a continuous cycle of identification, prevention and control of risks and harms. Preventative strategies were more commonly adopted after many years of anabolic steroid use. Changes in life circumstances and adverse health conditions were described as common triggers for changes in behaviour, including the cessation of anabolic steroid use.
conclusionOur findings can inform interventions aimed at increasing awareness and promoting healthier behaviours among people who use anabolic steroids. Further research is needed to evaluate the effectiveness and safety of the risk-management strategies employed by this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.